Artificial Intelligence

Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024

As we step into 2024, let's explore 15 AI companies at the forefront of this transformative journey. Atomwise: Revolutionizing Virtual Screening Atomw...

 December 27, 2023 | News

Oncoshot Collaborates with Zhejiang Ablaze for Data-Driven Drug Development in China

This collaboration brings together complementary strengths - Oncoshot's capabilities in data analysis and insights generation with Ablaze's recent expansio...

 December 26, 2023 | News

ArisGlobal Introduces LifeSphere® NavaX™ - The Next-Generation Cognitive Computing Engine

NavaX will revolutionize the end-to-end Research and Development processes with the latest advanced technologies ArisGlobal, a market leader in Life Scien...

 December 15, 2023 | News

Medtronic and Cosmo Pharmaceuticals forge ahead in AI-driven care

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announces that it has entered into a definitive agreement to expand its partnersh...

 December 12, 2023 | News

Merck Collaborates with Acceleration Consortium on Open-Sourcing AI-Driven Experimentation Planner

"The release and maintenance of open-source code for scientific discovery is imperative for the advancement of self-driving labs. This collaboration moves ...

 December 07, 2023 | News

Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis

  Combines generative AI, machine learning and computer-aided drug-design to increase the success rate of new drugs and therapies Virtually screen...

 December 06, 2023 | News

Lunit Advances Singapore's Healthcare with AI-Powered Medical Imaging Solution.

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, partners with NTT DATA Singapore to introduce Lu...

 December 01, 2023 | News

AWAK Technologies' AI Kidney Disease Prediction Tool Receives FDA Breakthrough Designation

The KDPP model helps to assess the risk of kidney disease progression and initiation of renal replacement therapy (dialysis or transplant), within a period...

 November 28, 2023 | News

Prospection AI Launches Single-source Patient-centric Platform in Australia to Boost Drug Commercialization

-Prospection—the pioneer of patient-centric intelligence—today announced the availability of Prospection AI, its self-service patient-cent...

 November 21, 2023 | News

Tempus Collaborates with Bristol Myers Squibb on Multimodal AI Research

"We are looking forward to expanding our relationship with Bristol Myers Squibb and furthering our shared commitment to advancing cancer research and treat...

 November 09, 2023 | News

XtalPi and CK Life Sciences Partner to Develop AI-Based Cancer Diagnostic Models

With the help of AI and machine learning models, this collaborative engagement will hopefully lead to the development of more advanced and intelligent solu...

 November 06, 2023 | News

GE Healthcare Validates AI Models for Immunotherapy Patient Response Prediction

New data supports the potential role of Artificial Intelligence (AI) in predicting patients’ response to immunotherapies in advance of their treatm...

 November 03, 2023 | News

Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced a research collaboration with The ...

 October 30, 2023 | News

Noul Reveals AI Diagnostic Results in Ethiopian and Ghanaian Malaria Study

Reaffirming innovation as an AI-based digital microscope while presenting new malaria data at the annual meeting of the ASTMH 2023 Noul's ...

 October 24, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close